Figures and Tables

From the following article:

Transient FTY720 treatment promotes immune-mediated clearance of a chronic viral infection

Mary Premenko-Lanier, Nelson B. Moseley, Sarah T. Pruett, Pablo A. Romagnoli & John D. Altman

Nature 454, 894-898(14 August 2008)

doi:10.1038/nature07199

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 1

LCMV Armstrong but not clone 13 induces profound lymphopenia at days 2 and 3 after infection.

Full size figure and legend (91K)Download PowerPoint slide (470K)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 2

Low-dose short-term FTY720 treatment of clone-13-infected mice prevents the establishment of a persistent LCMV infection.

Full size figure and legend (190K)Download PowerPoint slide (568K)
Figure 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 3

Low-dose short-term FTY720 treatment clears an established persistent clone 13 infection.

Full size figure and legend (147K)Download PowerPoint slide (526K)

Slides may be downloaded for educational use, according to the terms described in Nature Publishing Group's licensing policy.

BACK TO ARTICLE